The mechanism is that TGF-β1, a key suppressive cytokine in PD onset and development, was decreased in AQP4 deficient mice after MPTP treatment, which resulted from the impairment of its generation by astrocytes. This evidence concerns the gene AQP4 and Parkinson disease.